Syngene International Ltd

NSE :SYNGENE   BSE :539268  Sector : Pharmaceuticals
Buy, Sell or Hold SYNGENE? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

25 Apr
699.10
(0.73%)
24 Apr
694.00
(-1.01%)
23 Apr
701.05
(-0.60%)
22 Apr
705.25
(-1.21%)
19 Apr
713.90
(0.74%)
18 Apr
708.65
(-0.31%)
16 Apr
710.85
(-1.83%)
15 Apr
724.10
(-3.33%)
12 Apr
749.05
(2.33%)
10 Apr
732.00
(0.18%)
09 Apr
730.70
(0.23%)
08 Apr
729.00
(-0.07%)
05 Apr
729.50
(0.22%)
04 Apr
727.90
(0.91%)
03 Apr
721.35
(-0.28%)
02 Apr
723.40
(2.12%)
01 Apr
708.40
(0.83%)
28 Mar
702.55
(-1.32%)
27 Mar
711.95
(0.96%)
26 Mar
705.15
(0.96%)
22 Mar
698.45
(1.93%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Neutral
Long Term Investors

Very Bearish

Moving Averages

5 DMA
Bearish

702.5

10 DMA
Bearish

713.45

20 DMA
Bearish

715.85

50 DMA
Bearish

713.93

100 DMA
Bearish

715.48

200 DMA
Bearish

742.91


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 25, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 742.4 726.1 707.3 - -
R2 726.1 714.72 704.56 726.8 -
R1 712.6 707.68 701.83 714 719.35
P 696.3 696.3 696.3 697 699.68
S1 682.8 684.92 696.37 684.2 689.55
S2 666.5 677.88 693.64 667.2 -
S3 653 666.5 690.91 - -

Key Metrics

EPS

11.82

P/E

59.13

P/B

6.71

Dividend Yield

1.79%

Market Cap

28,141 Cr.

Face Value

10

Book Value

104.14

ROE

13.43%

EBITDA Growth

332 Cr.

Debt/Equity

0.27

Shareholding Pattern

  54.79% Total Promoter Holding
12.59% Mutual Fund Holdings
20.92% FIIs
8.17% Non Institution
1.7% Insurance Companies
0.31% Custodians
1.52% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Syngene International Ltd Quaterly Results


Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
INCOME 1017.2 831.7 931.7 882.8 933
PROFIT 178.7 93.4 122.22 114.49 188.6
EPS 4.36 2.33 2.9 2.78 4.7

Syngene International Ltd Quaterly Results


Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
INCOME 1017.2 738.7 851.7 820.7 880
PROFIT 189 75.3 107.35 102.76 189.8
EPS 4.71 1.88 2.53 2.49 4.73

Profit & Loss (Figures in Rs. Crores)


Syngene International Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 1498.4 1874.7 2164 2309.1 2678.6 3305.8
PROFIT 289.35 328.12 358.49 379.76 417.63 461.92
EPS 7.64 8.29 10.3 10.12 9.88 11.57

Syngene International Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 706.1 881.9 1117.7 1293.9 1498.4 1874.7 2164 2304.2 2730.6 3306.4
PROFIT 134.8 175 240.8 286.74 289.05 327.22 357.85 378.54 415.64 470.5
EPS 25.82 7.82 5.92 7.19 7.63 8.27 10.29 10.09 9.83 11.78

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 401.4400.8400400200200
Reserves Total 3,216.62,896.82,421.41,775.81,768.41,520.4
Total Shareholders Funds3,6183,297.62,821.42,175.81,968.41,720.4
Secured Loans 575.3531.5512.4376.7606.6692.6
Unsecured Loans 239.9490.1380.5396.2206.794.8
Total Debt815.21,021.6892.9772.9813.3787.4
Other Liabilities321.6295.6311.2366.7244.899.5
Total Liabilities4,754.84,614.84,025.53,315.43,026.52,607.3
APPLICATION OF FUNDS :
Gross Block 4,558.93,943.53,4603,017.22,1711,660.7
Less: Accumulated Depreciation1,8921,550.71,259997.5794.2630.3
Net Block2,666.92,392.82,2012,019.71,376.81,030.4
Capital Work in Progress176.9346.4237.2234.1273.7155.4
Investments 918.51,034.1702776.4716157.7
Inventories 332.8179.459.625.243.486
Sundry Debtors 529.3507.7475.7398.2338.7266.8
Cash and Bank Balance531.7517.9642.6281.5436.9967.4
Loans and Advances 207.1237.1205.5169.3229.1242.3
Total Current Assets1,600.91,442.11,383.4874.21,048.11,562.5
Current Liabilities 1,010.5866.8797.8794.3640.2555.4
Provisions 65.782.259.953.236.826.3
Total Current Liabilities & Provisions1,076.2949857.7847.5677581.7
Net Current Assets524.7493.1525.726.7371.1980.8
Deferred Tax Assets194.1190.7188.9208.3124.6118.4
Deferred Tax Liability124.5125.199.885.633.146
Net Deferred Tax69.665.689.1122.791.572.4
Other Assets398.2282.8270.5135.8197.4210.6
Total Assets4,754.84,614.84,025.53,315.43,026.52,607.3
Contingent Liabilities621.91,095.6859.6424.7335.9476.8
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 401.4400.8400400200200200200199.126.1
Reserves Total 3,217.52,891.22,418.31,774.11,767.21,520.11,224.4824.7645.8633.2
Equity Application Money000000-11.3000
Total Shareholders Funds3,618.93,2922,818.32,174.11,967.21,720.11,413.11,024.7844.9659.3
Secured Loans 575.3531.5512.4376.7606.6692.6689.889118.694.8
Unsecured Loans 63.3490.1380.5396.2206.794.8116.60136.460.1
Total Debt638.61,021.6892.9772.9813.3787.4806.4891155154.9
Other Liabilities319.6295.6311.2366.7244.899.571.671.677.964.1
Total Liabilities4,577.14,609.24,022.43,313.73,025.32,6072,291.11,987.31,077.8878.3
APPLICATION OF FUNDS :
Gross Block 4,071.23,943.53,4603,017.22,1711,660.71,331.91,111.4938394.1
Less : Accumulated Depreciation 1,811.21,550.71,259997.5794.2630.3521.5531.2434.70
Net Block 2,2602,392.82,2012,019.71,376.81,030.4810.4580.2503.3394.1
Capital Work in Progress126.2346.4237.2234.1273.7155.4174.9236.8105.145.3
Investments 940.81,034.4702.3776.7716.3158540.4276.6146352.1
Inventories 332.8179.459.625.243.48632.237.738.414.9
Sundry Debtors 484.4508.2474.4398.2338.7266.8198.7185.2179.994.3
Cash and Bank Balance509.3515.1638.2280.3435.4966.5527.3719.9115.791.6
Loans and Advances 733.4237.1205.5169.3229.1242.3225.5115.3105.881.2
Total Current Assets2,059.91,439.81,377.78731,046.61,561.6983.71,058.1439.8282
Current Liabilities 1,210.1869.4795.3795.1640.2555.2462.5350.8329.4297.8
Provisions 60.882.259.853.236.826.221.217.49.49.7
Total Current Liabilities & Provisions1,270.9951.6855.1848.3677581.4483.7368.2338.8307.5
Net Current Assets789488.2522.624.7369.6980.2500689.9101-25.5
Deferred Tax Assets201.6190.3188.5208.3124.6118.497.284.55.13.7
Deferred Tax Liability122.1125.299.885.633.14633.512.8108.8
Net Deferred Tax79.565.188.7122.791.572.463.771.7-4.9-5.1
Other Assets381.6282.3270.6135.8197.4210.6201.7132.1227.3117.4
Total Assets4,577.14,609.24,022.43,313.73,025.32,6072,291.11,987.31,077.8878.3
Contingent Liabilities621.9547.8859.6849.2671.6238.5376.6384.9110.4172.8

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...464.4
Depreciation366.5
Interest (Net)-25.9
P/L on Sales of Invest-10.6
Prov. and W/O (Net)-0.7
P/L in Forex24.5
Total Adjustments (PBT and Ext...514.1
Operating Profit before Workin...978.5
Trade and 0ther Receivables6.9
Inventories-153.4
Trade Payables202.2
Total Adjustments (OP before W...-18.2
Cash Generated from/(used in) ...960.3
Direct Taxes Paid-136.8
Total Adjustments(Cash Generat...-136.8
Cash Flow before Extraordinary...823.5
Net Cash from Operating Activi...823.5
Purchased of Fixed Assets-518.3
Purchase of Investments-1,633.5
Sale of Investments1,716.9
Interest Received54
Net Cash used in Investing Act...-653.3
Of the Short Term Borrowings-258.1
Of Financial Liabilities-9.8
Dividend Paid-40.1
Interest Paid-34.5
Net Cash used in Financing Act...-342.5
Net Profit before Tax and Extr...473
Depreciation359.1
Interest (Net)-25.9
P/L on Sales of Invest-10.6
Prov. and W/O (Net)-0.7
P/L in Forex24.5
Total Adjustments (PBT and Ext...503.2
Operating Profit before Workin...976.2
Trade and 0ther Receivables7.1
Inventories-153.4
Trade Payables221.3
Total Adjustments (OP before W...-4.1
Cash Generated from/(used in) ...972.1
Direct Taxes Paid-133.7
Total Adjustments(Cash Generat...-133.7
Cash Flow before Extraordinary...838.4
Net Cash from Operating Activi...838.4
Purchased of Fixed Assets-533.1
Purchase of Investments-1,655.5
Sale of Investments1,716.9
Interest Received54
Net Cash used in Investing Act...-685.1
Of the Short Term Borrowings-258.1
Of Financial Liabilities-7.6
Dividend Paid-40.1
Interest Paid-34.4
Net Cash used in Financing Act...-340.2

Company Details

Registered Office
AddressBiocon SEZ Biocon Park,
Plot No 2 & 3 Bommasandra Inds
CityBengaluru
StateKarnataka
Pin Code560099
Tel. No.91-80-68915000/67758781
Fax. No.91-80-28083189
Emailinvestor@syngeneintl.com; Mayank.Verma@syngeneintl
Internethttp://www.syngeneintl.com
Registrars
AddressBiocon SEZ Biocon Park
CityBengaluru
StateKarnataka
Pin Code560099
Tel. No.91-80-68915000/67758781
Fax. No.91-80-28083189
Emailinvestor@syngeneintl.com; Mayank.Verma@syngeneintl
Internethttp://www.syngeneintl.com
Management
Name Designation
Kiran Mazumdar ShawChairperson
Catherine Patricia RosenbergDirector
Paul Frederick BlackburnIndependent Director
Vijay KuchrooIndependent Director
Jonathan HuntManaging Director & CEO
Vinita BaliLead Independent Director
Priyadarshnini MahapatraCompany Sec. & Compli. Officer
Sharmila KarveIndependent Director
Carl DeciccoDirector
Kush ParmarIndependent Director